To study the impact of CD44-positive myeloid cells on glioma growth and progression in vivo, we carried out intracranial orthotopic injections in CD44fl/fl (floxed) and Csf1r-Cre/CD44fl/fl conditional knockout (cKO) mice. The gene discussed is CD44; the disease is glioma.